<?xml version="1.0" encoding="UTF-8"?>
<p>The main drawback to define tailored safety recommendations for patients with immunodeficiencies arises from our lack of knowledge regarding immune mechanisms during COVID‐19. Cytotoxic lymphocytes, essential to control viral infections, were described to be markedly decreased in total cell numbers, and NK and CD8
 <sup>+</sup> T cell function was exhausted in patients with COVID‐19 infection.
 <xref rid="pai13262-bib-0038" ref-type="ref">
  <sup>38</sup>
 </xref> Moreover, Toll‐like receptor 7 activation associated with alpha‐interferon and TNF‐alpha as well as IL‐12 and IL‐6 production seem to play an essential role in the control of the viral infection.
 <xref rid="pai13262-bib-0039" ref-type="ref">
  <sup>39</sup>
 </xref>
</p>
